2-Bromo-1-(2-cyclopropylmethoxypyrimidin-5-yl)ethanone → (8S)-2-chloro-9-[2-(2-cyclopropylmethoxypyrimidin-5-yl)-2-oxoethyl]-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one
反応式
[Cl:1][C:2]1[N:3]=[C:4]2[NH:12][C@H:11]([C:13]([F:16])([F:15])[F:14])[CH2:10][CH2:9][N:5]2[C:6](=[O:8])[CH:7]=1.Br[CH2:18][C:19]([C:21]1[CH:22]=[N:23][C:24]([O:27][CH2:28][CH:29]2[CH2:31][CH2:30]2)=[N:25][CH:26]=1)=[O:20]>>[Cl:1][C:2]1[N:3]=[C:4]2[N:12]([CH2:18][C:19]([C:21]3[CH:26]=[N:25][C:24]([O:27][CH2:28][CH:29]4[CH2:31][CH2:30]4)=[N:23][CH:22]=3)=[O:20])[C@H:11]([C:13]([F:14])([F:15])[F:16])[CH2:10][CH2:9][N:5]2[C:6](=[O:8])[CH:7]=1参加物
3
反応物 2
生成物 1
実験手順
180 mg (0.71 mmol) of (8S)-2-chloro-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 211.66 mg (0.78 mmol) of 2-bromo-1-(2-cyclopropylmethoxypyrimidin-5-yl)ethanone were used in the reaction. After purification by chromatography on silica gel (eluent: 80/20 DCM/MeOH), 160 mg of (8S)-2-chloro-9-[2-(2-cyclopropylmethoxypyrimidin-5-yl)-2-oxoethyl]-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one are obtained, the characteristics of which are as follows:
後処理
- customAfter purification by chromatography on silica gel (eluent: 80/20 DCM/MeOH), 160 mg of (8S)-2-chloro-9-[2-(2-cyclopropylmethoxypyrimidin-5-yl)-2-oxoethyl]-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one
- customare obtained
出典と根拠
- ORDレコード
- ord-8585551b88844dd7a030d9b360023c0d
- 出典データセット
- uspto-grants-2016_04
- 特許番号
- US09321790B2
反応ノート
読み込み中…